Clearmind Medicine Inc (CMND)
1.23
-0.06
(-4.65%)
USD |
NASDAQ |
May 17, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Total Liabilities (Quarterly): 5.056M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 5.056M |
| October 31, 2023 | 3.594M |
| July 31, 2023 | 1.253M |
| April 30, 2023 | 1.943M |
| January 31, 2023 | 0.8007M |
| October 31, 2022 | 1.420M |
| July 31, 2022 | 0.6041M |
| April 30, 2022 | 0.1912M |
| January 31, 2022 | 0.1503M |
| October 31, 2021 | 0.2882M |
| July 31, 2021 | 0.3525M |
| April 30, 2021 | 0.0231M |
| Date | Value |
|---|---|
| January 31, 2021 | 0.0252M |
| October 31, 2020 | 0.01M |
| July 31, 2020 | 0.011M |
| April 30, 2020 | 0.0187M |
| January 31, 2020 | 0.0523M |
| October 31, 2019 | 0.0338M |
| July 31, 2019 | 0.0233M |
| April 30, 2019 | 0.0215M |
| January 31, 2019 | 0.0016M |
| October 31, 2018 | 0.0058M |
| July 31, 2018 | 0.049M |
| April 30, 2018 | 0.0504M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.01M
Minimum
Oct 2020
5.056M
Maximum
Jan 2024
0.8342M
Average
0.1912M
Median
Apr 2022
Total Liabilities (Quarterly) Benchmarks
| SciSparc Ltd | 1.595M |
| ImmunoPrecise Antibodies Ltd | 21.54M |
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.10M |
| Shareholders Equity (Quarterly) | 5.041M |